Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Effectiveness and Safety of Endovascular Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation. Insights from Latin America: A Systematic Review and Meta-analysis
Cerebrovascular Disease and Interventional Neurology
S41 - Sociodemographics of Stroke and Policy in Stroke Care (2:24 PM-2:36 PM)
008

Recent studies have demonstrated better functional outcomes for EVT in patients with PCAIS. However, there is scarcity of data in Latin America, a region with its own socio demographic and health-related characteristics and with patients who tend to have a poorer prognosis after a stroke.

To assess the safety and efficacy of Endovascular Thrombectomy (EVT) in adults with posterior circulation acute ischemic stroke (PCAIS) in Latin America.

A systematic search was performed in PubMed, Embase, SCOPUS, WOS, Lilacs and Scielo for studies conducted up to September 2023. Studies aiming to assess the safety and efficacy of EVT in Latin American adults with PCAIS were selected. Outcomes of interest included functional independence (90-day mRS 0-3), symptomatic intracerebral hemorrhage (sICH), and all-cause mortality at 90 days. Quality assessment was performed using Cochrane Risk of bias 2 tool and NewCastle-Ottawa for observational studies. A single-arm and a random effects model meta-analysis of proportions were conducted, using the I2 statistics to measure the statistical heterogeneity.

A total of 2557 studies were screened, and ten studies were selected, representing a total of 224 patients with PCAIS. All of them were observational studies. Bridging with Intravenous thrombolysis was reported in most studies. The pool proportion of patients with functional independence was 36% CI 95% [29%, 45%]; Pooled proportions for mortality and sICH were 8% CI 95% [4%,15%] and 38% CI 95% [30%,46%], respectively. Only two studies reported EVT vs other treatments (n=24), showing a pooled OR of 2.17 CI 95% [0.96; 4.91]. Quality assessment showed low to medium risk of bias.

Our findings show similar efficacy to other studies; however, mortality and sICH appear to be higher. EVT could be a promising technique for PCAIS, however randomized controlled trials are needed to adequately evaluate the outcomes of EVT vs standard of treatment in Latin America.

Authors/Disclosures
Karlos A. Acurio, MD (Universidad Peruana Cayetano Heredia)
PRESENTER
Mr. Acurio has nothing to disclose.
Niels V. Pacheco, MD Mr. Pacheco has nothing to disclose.
Fritz F. Vascones Roman, Sr. Mr. Vascones Roman has nothing to disclose.
Fernando J. Canazas-Paredes Mr. Canazas-Paredes has nothing to disclose.
Irving G. Calisaya-Madariaga, Sr. (Universidad Peruana Cayetano Heredia) Mr. Calisaya-Madariaga has nothing to disclose.
Diego F. Zambrano Mr. Zambrano has nothing to disclose.
Esteban Alarcon-Braga Mr. Alarcon-Braga has nothing to disclose.
Juan R. Carhuapoma, MD (THe Johns Hopkins Hospital) Dr. Carhuapoma has nothing to disclose.